8-K ·Filed Mar 11, 2026
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral
Monitor for release of the full filing or related press statements; current lack of content prevents assessment of potential stock impact.
Final — all horizons settled through T+60d ⚠ clustered
QNRX ▼ -44.50% at T+60d
NEUTRAL call ✗ call lost -44.50% · α vs SPY -55.20% · entry $8.09 → $4.49
T+1d
-0.37%
call -0.37% · α +0.23%
$8.06
settled 7mo ago
T+5d
+2.10%
call +2.10% · α +3.08%
$8.26
settled 7mo ago
T+20d
-27.07%
call -27.07% · α -29.05%
$5.90
settled 6mo ago
T+60d
-44.50%
call -44.50% · α -55.20%
$4.49
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Quoin Pharmaceuticals, Ltd. (QNRX) includes Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), but no substantive details were accessible to determine the nature or impact of the disclosed events.
Key Facts
- Filing is an 8-K report for Quoin Pharmaceuticals, Ltd. (QNRX)
- Items disclosed: 7.01 (Regulation FD Disclosure), 8.01 (Other Events), 9.01 (Exhibits)
- No document content was available for analysis
- Market cap of QNRX is $93M as of snapshot
Financial Impact
Not specified
Risk Factors
- Inability to assess materiality of disclosed events
- Potential for delayed market reaction if significant news is contained in unreleased exhibits
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
14 reports for QNRX
50% Hit rate best @ T+5▲ +18.63%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 12, 2026 6d ago | ANALYST-UPGRADE | $4.36 $4.15 | ▼ −4.82% | ▼ −4.80% | $3.90 (−10.55%) |
Sep 2, 2026 6w ago | Insider Cluster | $6.74 $7.87 | ▲ +16.77% | ▲ +15.72% | $3.90 (−42.14%) |
Aug 28, 2026 7w ago | 8-K | $6.12 $6.22 | ▲ +1.63% | ▲ +1.93% | $3.90 (−36.27%) |
Aug 28, 2026 7w ago | Press Release | $6.12 $6.22 | ▼ −1.63% | ▼ −1.93% | $3.90 (+36.27%) |
Aug 28, 2026 7w ago | Press Release | $6.12 $6.22 | ▲ +1.63% | ▲ +1.93% | $3.90 (−36.27%) |
Aug 20, 2026 8w ago | 8-K | $5.57 $5.42 | ▼ −2.69% | ▼ −2.40% | $3.90 (−29.98%) |
Aug 7, 2026 10w ago | Press Release | $4.79 $5.36 | ▲ +11.90% | ▲ +11.93% | $3.90 (−18.58%) |
Jun 23, 2026 16w ago | 8-K | $3.83 $4.20 | ▲ +9.66% | ▲ +9.52% | $3.90 (+1.83%) |
May 7, 2026 23w ago | Press Release | $6.37 $5.93 | ▼ −6.91% | ▼ −7.74% | $3.90 (−38.78%) |
May 5, 2026 23w ago | ANALYST-UPGRADE | $6.31 $6.43 | ▲ +1.90% | ▲ +0.52% | $3.90 (−38.19%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 5h 50m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access